Romosozumab Associated with Lower Osteoporotic Fracture Risk than Alendronate (FREE)

By Joe Elia Edited by David G. Fairchild, MD, MPH, and Jaye Elizabeth Hefner, MD Romosozumab outperformed alendronate in lowering osteoporosis-related fracture risk, according to an industry-conducted, phase 3 study published in the New …
Source: Physician's First Watch current issue - Category: Primary Care Source Type: news